Heart risk clues found in sarcoma chemo patients
NCT ID NCT06511388
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times
Summary
This study aimed to find early warning signs of heart failure in people with sarcoma who receive chemotherapy. Researchers used advanced heart ultrasound techniques to track changes in heart function over time. The goal was to identify which patients are at highest risk, so doctors can monitor them more closely. The study was terminated early, but the data may still help improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.